These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 35734997)

  • 1. Assessing the use of methotrexate as an alternate therapy for pemphigus vulgaris and pemphigus foliaceus.
    Kolla A; Shah P; Cymerman R; Fruchter R; Adotama P; Soter NA
    Dermatol Ther; 2022 Aug; 35(8):e15661. PubMed ID: 35734997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of cyclophosphamide, azathioprine, and cyclosporine (ciclosporin) as adjuvant drugs in pemphigus vulgaris.
    Olszewska M; Kolacinska-Strasz Z; Sulej J; Labecka H; Cwikla J; Natorska U; Blaszczyk M
    Am J Clin Dermatol; 2007; 8(2):85-92. PubMed ID: 17428113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methotrexate in the treatment of pemphigus vulgaris: experience in 23 patients.
    Tran KD; Wolverton JE; Soter NA
    Br J Dermatol; 2013 Oct; 169(4):916-21. PubMed ID: 23772610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of rituximab and conventional adjuvant therapy for pemphigus vulgaris: A retrospective analysis.
    Agarwal A; Hall RP; Bañez LL; Cardones AR
    PLoS One; 2018; 13(9):e0198074. PubMed ID: 30252855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of pemphigus vulgaris with brief, high-dose intravenous glucocorticoids.
    Werth VP
    Arch Dermatol; 1996 Dec; 132(12):1435-9. PubMed ID: 8961871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Yearly reduction of glucocorticoid dose by 50% as tapering schedule achieves complete remission for 124 pemphigus vulgaris patients.
    Wang M; Gao Y; Peng Y; Zhao J; Chen X; Zhu X
    J Dermatol; 2016 Mar; 43(3):325-8. PubMed ID: 26332949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of Pemphigus Vulgaris and Foliaceus with Adjuvant Rituximab Compared to Immunosuppression Alone: Real-Life Experience.
    Snast I; Spitzer L; Hodak E; Levi A; Mimouni D; Leshem YA
    Dermatology; 2021; 237(2):179-184. PubMed ID: 32756069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of pemphigus vulgaris and pemphigus foliaceus: a systematic review and meta-analysis.
    Atzmony L; Hodak E; Gdalevich M; Rosenbaum O; Mimouni D
    Am J Clin Dermatol; 2014 Dec; 15(6):503-15. PubMed ID: 25403548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of pemphigus vulgaris and pemphigus foliaceus with mycophenolate mofetil.
    Mimouni D; Anhalt GJ; Cummins DL; Kouba DJ; Thorne JE; Nousari HC
    Arch Dermatol; 2003 Jun; 139(6):739-42. PubMed ID: 12810504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feline pemphigus foliaceus in non-specialist veterinary practice: a retrospective analysis.
    Coyner K; Tater K; Rishniw M
    J Small Anim Pract; 2018 Sep; 59(9):553-559. PubMed ID: 29961990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enteric-coated mycophenolate sodium as a steroid-sparing agent in pemphigus treatment: a retrospective study.
    De Simone C; Caldarola G; Perino F; Venier A; Guerriero G
    Dermatol Ther; 2012; 25(2):219-22. PubMed ID: 22741942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rituximab is an effective treatment in patients with pemphigus vulgaris and demonstrates a steroid-sparing effect.
    Chen DM; Odueyungbo A; Csinady E; Gearhart L; Lehane P; Cheu M; Maho-Vaillant M; Prost-Squarcioni C; Hebert V; Houivet E; Calbo S; Caillot F; Golinski ML; Labeille B; Picard-Dahan C; Paul C; Richard MA; Bouaziz JD; Duvert-Lehembre S; Bernard P; Caux F; Alexandre M; Ingen-Housz-Oro S; Vabres P; Delaporte E; Quereux G; Dupuy A; Debarbieux S; Avenel-Audran M; D'Incan M; Bedane C; Bénéton N; Jullien D; Dupin N; Misery L; Machet L; Beylot-Barry M; Dereure O; Sassolas B; Benichou J; Musette P; Joly P;
    Br J Dermatol; 2020 May; 182(5):1111-1119. PubMed ID: 31487383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of the rate of long-term complete remission off therapy in patients with pemphigus treated with different regimens including medium- and high-dose corticosteroids.
    Almugairen N; Hospital V; Bedane C; Duvert-Lehembre S; Picard D; Tronquoy AF; Houivet E; D'incan M; Joly P
    J Am Acad Dermatol; 2013 Oct; 69(4):583-8. PubMed ID: 23850258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interventions for pemphigus vulgaris and pemphigus foliaceus.
    Martin LK; Werth V; Villanueva E; Segall J; Murrell DF
    Cochrane Database Syst Rev; 2009 Jan; (1):CD006263. PubMed ID: 19160272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Steroid sparing effect of intravenous immunoglobulin therapy in patients with pemphigus foliaceus.
    Sami N; Qureshi A; Ahmed AR
    Eur J Dermatol; 2002; 12(2):174-8. PubMed ID: 11872417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pemphigus vulgaris: results of treatment with gold as a steroid-sparing agent in a series of thirteen patients.
    Poulin Y; Perry HO; Muller SA
    J Am Acad Dermatol; 1984 Nov; 11(5 Pt 1):851-7. PubMed ID: 6439764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steroid-pulse therapy in pemphigus vulgaris long term follow-up.
    Chryssomallis F; Dimitriades A; Chaidemenos GC; Panagiotides D; Karakatsanis G
    Int J Dermatol; 1995 Jun; 34(6):438-42. PubMed ID: 7657447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methotrexate is an effective and safe adjuvant therapy for pemphigus vulgaris.
    Baum S; Greenberger S; Samuelov L; Solomon M; Lyakhovitsky A; Trau H; Barzilai A
    Eur J Dermatol; 2012; 22(1):83-7. PubMed ID: 22266247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of the guideline-based treatment for pemphigus: a single-centre experience with 84 cases.
    Kakuta R; Kurihara Y; Yamagami J; Miyamoto J; Funakoshi T; Tanikawa A; Amagai M
    J Eur Acad Dermatol Venereol; 2020 Jun; 34(6):1324-1330. PubMed ID: 31923338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic effect of mizoribine on pemphigus vulgaris and pemphigus foliaceus.
    Hashimoto T; Kawakami T; Koga H; Ohyama B; Hamada T; Dainichi T; Nakama T; Yasumoto S; Tsuruta D; Ishii N
    Dermatol Ther; 2012; 25(4):382-5. PubMed ID: 22950566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.